Serotonin Myth.
2 posters
Page 1 of 1
Serotonin Myth.
As the authors of a paper in PLoS Medicine noted: "To our knowledge, there is not a single peer-reviewed article that can be accurately cited to directly support claims of serotonin deficiency in any mental disorder, while there are many articles that present counterevidence."
Remember Hufeza was discussing in depth about anti-depressants few months ago.
The plos med article linked above is fantastic.
St.John Wort's and exercise outperformed SSRIs in treating depression as evidenced by recent clinical trials.
The Chemical Imbalance Myth
by KAS THOMAS MAY 8, 2013, 10:09 AM
Very few countries allow direct-to-consumer advertising by drug companies, but in those that do (New Zealand, Canada, and the U.S.), the medicine-buying public has been brainwashed to believe that mental illnesses, particularly those involving depression, are caused by a "chemical imbalance in the brain." Hundreds of billions of dollars of Proxac, Zoloft, Paxil, Celexa, and other popular antidepressants have been sold on the basis of their being able to restore normal serotonin levels to out-of-whack brain cells.
The trouble is, there's no evidence that depression is caused by a serotonin imbalance. And there's no simple blood or urine test that will tell you if neurotransmitter levels in your brain are out of whack. (Serotonin doesn't cross the Blood Brain Barrier. Hence, a blood test would be meaningless.) Even if there were such a test, the mere finding that serotonin is too low (or too high) in your brain isn't enough, by itself, to establish a causal connection with how you feel. Saying that because serotonin reuptake inhibitors help treat depression, therefore depression is a disorder of serotonin imbalance in the brain, is like saying that because I'm unfocused in the morning until I have coffee, therefore I have Morning Attention Deficit Disorder caused by an imbalance of purines in my brain. (Caffeine is an antagonist of adenine receptors.) From there, it's only one step away to the chocolate-imbalance theory of lovesickness, the Red Bull imbalance theory of fatigue, and equally cockamamie theories.
As the authors of a paper in PLoS Medicine noted: "To our knowledge, there is not a single peer-reviewed article that can be accurately cited to directly support claims of serotonin deficiency in any mental disorder, while there are many articles that present counterevidence."
Serotonin-imbalance theorists have yet to reconcile the fact that while some depressed patients respond to SSRIs, some also repond to SNRIs (drugs that affect norepinephrine and serotonin levels), whereas others respond to drugs like mirtazapine that affect norepinephrine and dopamine and serotonin (or dopamine and norepinephrine in the case of bupropion), whereas for other patients (namely those who respond to tricyclics) therapeutic action involves an intricate combination of imbalances related to serotonin, norepinephrine, and dopamine transporters (SERT and NET and DAT) as well as the H1 histamine receptor, the 1A and 2A serotonin receptors, α1 and α2 adrinergic receptors, the D2 dopamine receptor, and the muscarinic acetylcholine receptor. That's an awful lot of different types of "chemical imbalance," for one illness. The literature shows that depressed patients tend to respond more-or-less equally well to any of the major categories of antidepressants (this was the major finding of the six-year, $35 million STAR*D study) , basically proving that these drugs are not highly specific in their effects. If they were indeed highly specific to certain types of depression (if some patients specifically needed an SNRI, whereas others specifically needed an SSRI, whereas others needed a tricyclic, etc.) then the patient subpopulations would add up to more than 100% of the total patient population, based on how many people tend to respond to each type of drug.
Then there's the somewhat curious fact that tianeptine, an antidepressant marketed for many years under the name Coaxil in Europe and South America, is actually a selective serotonin reuptake enhancer (not inhibitor). So apparently, some depression is caused by too much serotonin.
Researchers who've tried to induce depressive symptoms in normal subjects by lowering their endogenous serotonin levels (through a well-known dietary trick) have consistently been unable to do so. (E.g., Salomon et al., "Lack of behavioral effects of monoamine depletion in healthy subjects," Biological Psychiatry, 1 January 1997, 41:1, 58–64.) This elementary result is rarely discussed.
The Zoloft web site promotes Zoloft (an SSRI) as a treatment for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), and Social Anxiety Disorder (SAD). As the authors of one paper noted: "For the serotonin hypothesis to be correct as currently presented, serotonin regulation would need to be the cause (and remedy) of each of these disorders. This is improbable, and no one has yet proposed a cogent theory explaining how a singular putative neurochemical abnormality could result in so many wildly differing behavioral manifestations." See Lacasse, J.R., and Leo, J. (2005), "Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature," PLoS Med 2(12):e392.
The Code of Federal Regulations under which direct-to-consumer drug advertising is regulated states that an advertisement may be cited as false or misleading if it "[c]ontains claims concerning the mechanism or site of drug action that are not generally regarded as established by scientific evidence by experts qualified by scientific training and experience without disclosing that the claims are not established and the limitations of the supporting evidence…" Direct-to-consumer advertisements are also forbidden to include content that "contains favorable information or opinions about a drug previously regarded as valid but which have been rendered invalid by contrary and more credible recent information." Despite this, we still find the Paxil website saying (quite falsely): "Paxil can help restore the balance of serotonin (a naturally occurring chemical in the brain) -- which helps reduce the symptoms of anxiety and depression." Oddly, the FDA has never once cited a pharmaceutical company for these sorts of falsehoods, which have been presented over and over again in direct-to-consumer advertising about antidepressants.
It would be easier to accept neurotransmitter-imbalance theories of depression if the drugs in question worked with the same high degree of efficacy that, say, aspirin works for a headache or that insulin does for diabetes, but in fact the drugs work so poorly that the number one bestselling drug in America right now is an adjunctive drug sold on the basis of helping antidepressants work better (Abilify). When I mentioned this to a (non-depressed) friend of mine, and told him the retail price of a month's worth of Abilify (5mg, 30 pills) is a whopping $683 (making Abilify many times more valuable, ounce for ounce, than pure gold), his comment was: "Why don't you just go lease a new Acura and see if that doesn't cheer you up? It'd be cheaper, and more satisfying."
Personally, I think my friend is right. Everybody on Medicare, Medicaid, or prviate insurance who's receiving Abilify at subsidized rates should be offered a choice: continue to receive Abilify, or start driving a new Acura at no cost.
I wonder which one people would choose?
Additional Reading
For more on this subject, I recommend: "The Chemical Imbalance Explanation for Depression: Origins, Lay Endorsement, and Clinical Implications" by Christopher M. France, Paul H. Lysaker, and Ryan P. Robinson, in Professional Psychology: Research and Practice, 2007, 38:4, 411–420, full version here.
Also see Lacasse, Jeffrey R., and Leo, Jonathan, "Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature," PLoS Med 2(12): e392, full version here.
Remember Hufeza was discussing in depth about anti-depressants few months ago.
The plos med article linked above is fantastic.
St.John Wort's and exercise outperformed SSRIs in treating depression as evidenced by recent clinical trials.
The Chemical Imbalance Myth
by KAS THOMAS MAY 8, 2013, 10:09 AM
Very few countries allow direct-to-consumer advertising by drug companies, but in those that do (New Zealand, Canada, and the U.S.), the medicine-buying public has been brainwashed to believe that mental illnesses, particularly those involving depression, are caused by a "chemical imbalance in the brain." Hundreds of billions of dollars of Proxac, Zoloft, Paxil, Celexa, and other popular antidepressants have been sold on the basis of their being able to restore normal serotonin levels to out-of-whack brain cells.
The trouble is, there's no evidence that depression is caused by a serotonin imbalance. And there's no simple blood or urine test that will tell you if neurotransmitter levels in your brain are out of whack. (Serotonin doesn't cross the Blood Brain Barrier. Hence, a blood test would be meaningless.) Even if there were such a test, the mere finding that serotonin is too low (or too high) in your brain isn't enough, by itself, to establish a causal connection with how you feel. Saying that because serotonin reuptake inhibitors help treat depression, therefore depression is a disorder of serotonin imbalance in the brain, is like saying that because I'm unfocused in the morning until I have coffee, therefore I have Morning Attention Deficit Disorder caused by an imbalance of purines in my brain. (Caffeine is an antagonist of adenine receptors.) From there, it's only one step away to the chocolate-imbalance theory of lovesickness, the Red Bull imbalance theory of fatigue, and equally cockamamie theories.
As the authors of a paper in PLoS Medicine noted: "To our knowledge, there is not a single peer-reviewed article that can be accurately cited to directly support claims of serotonin deficiency in any mental disorder, while there are many articles that present counterevidence."
Serotonin-imbalance theorists have yet to reconcile the fact that while some depressed patients respond to SSRIs, some also repond to SNRIs (drugs that affect norepinephrine and serotonin levels), whereas others respond to drugs like mirtazapine that affect norepinephrine and dopamine and serotonin (or dopamine and norepinephrine in the case of bupropion), whereas for other patients (namely those who respond to tricyclics) therapeutic action involves an intricate combination of imbalances related to serotonin, norepinephrine, and dopamine transporters (SERT and NET and DAT) as well as the H1 histamine receptor, the 1A and 2A serotonin receptors, α1 and α2 adrinergic receptors, the D2 dopamine receptor, and the muscarinic acetylcholine receptor. That's an awful lot of different types of "chemical imbalance," for one illness. The literature shows that depressed patients tend to respond more-or-less equally well to any of the major categories of antidepressants (this was the major finding of the six-year, $35 million STAR*D study) , basically proving that these drugs are not highly specific in their effects. If they were indeed highly specific to certain types of depression (if some patients specifically needed an SNRI, whereas others specifically needed an SSRI, whereas others needed a tricyclic, etc.) then the patient subpopulations would add up to more than 100% of the total patient population, based on how many people tend to respond to each type of drug.
Then there's the somewhat curious fact that tianeptine, an antidepressant marketed for many years under the name Coaxil in Europe and South America, is actually a selective serotonin reuptake enhancer (not inhibitor). So apparently, some depression is caused by too much serotonin.
Researchers who've tried to induce depressive symptoms in normal subjects by lowering their endogenous serotonin levels (through a well-known dietary trick) have consistently been unable to do so. (E.g., Salomon et al., "Lack of behavioral effects of monoamine depletion in healthy subjects," Biological Psychiatry, 1 January 1997, 41:1, 58–64.) This elementary result is rarely discussed.
The Zoloft web site promotes Zoloft (an SSRI) as a treatment for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), and Social Anxiety Disorder (SAD). As the authors of one paper noted: "For the serotonin hypothesis to be correct as currently presented, serotonin regulation would need to be the cause (and remedy) of each of these disorders. This is improbable, and no one has yet proposed a cogent theory explaining how a singular putative neurochemical abnormality could result in so many wildly differing behavioral manifestations." See Lacasse, J.R., and Leo, J. (2005), "Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature," PLoS Med 2(12):e392.
The Code of Federal Regulations under which direct-to-consumer drug advertising is regulated states that an advertisement may be cited as false or misleading if it "[c]ontains claims concerning the mechanism or site of drug action that are not generally regarded as established by scientific evidence by experts qualified by scientific training and experience without disclosing that the claims are not established and the limitations of the supporting evidence…" Direct-to-consumer advertisements are also forbidden to include content that "contains favorable information or opinions about a drug previously regarded as valid but which have been rendered invalid by contrary and more credible recent information." Despite this, we still find the Paxil website saying (quite falsely): "Paxil can help restore the balance of serotonin (a naturally occurring chemical in the brain) -- which helps reduce the symptoms of anxiety and depression." Oddly, the FDA has never once cited a pharmaceutical company for these sorts of falsehoods, which have been presented over and over again in direct-to-consumer advertising about antidepressants.
It would be easier to accept neurotransmitter-imbalance theories of depression if the drugs in question worked with the same high degree of efficacy that, say, aspirin works for a headache or that insulin does for diabetes, but in fact the drugs work so poorly that the number one bestselling drug in America right now is an adjunctive drug sold on the basis of helping antidepressants work better (Abilify). When I mentioned this to a (non-depressed) friend of mine, and told him the retail price of a month's worth of Abilify (5mg, 30 pills) is a whopping $683 (making Abilify many times more valuable, ounce for ounce, than pure gold), his comment was: "Why don't you just go lease a new Acura and see if that doesn't cheer you up? It'd be cheaper, and more satisfying."
Personally, I think my friend is right. Everybody on Medicare, Medicaid, or prviate insurance who's receiving Abilify at subsidized rates should be offered a choice: continue to receive Abilify, or start driving a new Acura at no cost.
I wonder which one people would choose?
Additional Reading
For more on this subject, I recommend: "The Chemical Imbalance Explanation for Depression: Origins, Lay Endorsement, and Clinical Implications" by Christopher M. France, Paul H. Lysaker, and Ryan P. Robinson, in Professional Psychology: Research and Practice, 2007, 38:4, 411–420, full version here.
Also see Lacasse, Jeffrey R., and Leo, Jonathan, "Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature," PLoS Med 2(12): e392, full version here.
doofus_maximus- Posts : 1903
Join date : 2011-04-29
Re: Serotonin Myth.
dangerous effects of direct to consumer advt (DTCA)
A recent study by Kravitz et al. found that pseudopatients (actors who were trained to behave as patients) presenting with symptoms of adjustment disorder (a condition for which antidepressants are not usually prescribed) were frequently prescribed paroxetine (Paxil) by their physicians if they inquired specifically about Paxil [45]; such enquiries from actual patients could be prompted by DTCA [45].
In 1998, at the dawn of consumer advertising of SSRIs, Professor Emeritus of Neuroscience Elliot Valenstein summarized the scientific data by concluding, “What physicians and the public are reading about mental illness is by no means a neutral reflection of all the information that is available” [50]. The current state of affairs has only confirmed the veracity of this conclusion. The incongruence between the scientific literature and the claims made in FDA-regulated SSRI advertisements is remarkable, and possibly unparalleled.
A recent study by Kravitz et al. found that pseudopatients (actors who were trained to behave as patients) presenting with symptoms of adjustment disorder (a condition for which antidepressants are not usually prescribed) were frequently prescribed paroxetine (Paxil) by their physicians if they inquired specifically about Paxil [45]; such enquiries from actual patients could be prompted by DTCA [45].
In 1998, at the dawn of consumer advertising of SSRIs, Professor Emeritus of Neuroscience Elliot Valenstein summarized the scientific data by concluding, “What physicians and the public are reading about mental illness is by no means a neutral reflection of all the information that is available” [50]. The current state of affairs has only confirmed the veracity of this conclusion. The incongruence between the scientific literature and the claims made in FDA-regulated SSRI advertisements is remarkable, and possibly unparalleled.
doofus_maximus- Posts : 1903
Join date : 2011-04-29
Re: Serotonin Myth.
doofus_maximus wrote:As the authors of a paper in PLoS Medicine noted: "To our knowledge, there is not a single peer-reviewed article that can be accurately cited to directly support claims of serotonin deficiency in any mental disorder, while there are many articles that present counterevidence."
Remember Hufeza was discussing in depth about anti-depressants few months ago.
The plos med article linked above is fantastic.
St.John Wort's and exercise outperformed SSRIs in treating depression as evidenced by recent clinical trials.
The Chemical Imbalance Myth
by KAS THOMAS MAY 8, 2013, 10:09 AM
As always I am vindicated... Ever since the insurance companies began treating Peesichiatrists as equal to Real Physicians, this hang has been raping the population of their monies.
99% of the Peesichiatrists have no idea what these drugs do inside the brain. Every guy puts patients on Abilify, seroquel, Effexor and multiple regimen for same condition.. with crazy side effects...
Include Peesichiatrists in the group of Yem BEE AAs, Liars, and used car salesmen.
Marathadi-Saamiyaar- Posts : 17675
Join date : 2011-04-30
Age : 110
Re: Serotonin Myth.
can you give me a link to the above clinical trial?doofus_maximus wrote:
Remember Hufeza was discussing in depth about anti-depressants few months ago.
The plos med article linked above is fantastic.
St.John Wort's and exercise outperformed SSRIs in treating depression as evidenced by recent clinical trials.
a few things:
(i) it is pretty much accepted that "chemical imbalance" or "lack of serotonin" is NOT the reason for depression so there is no point emphasizing it again. how they cure depression (to my mind they do) is still unknown -- there are a lot of complex factors in the brain and it is difficult to ascertain how an SSRI works (to lift depression);
(ii) i have no personal experience if SSRI cures depression because my depression was caused by an abrupt cessation of a benzodiazepine and the reintroduction of the benzo resolved the depression but unfortunately an SSRI got added to the mix;
(iii) i have seen several cases of people suffering from debilitating depression for years who found relief with SSRIs. yes they tried exercise, st john's wort, yoga, gluten free diet, tryptophan and turkey before trying the SSRI. it is natural human psychology to try all the alternative methods before getting on something as potent as an SSRI. however my observations are NOT the findings of a clinical trial. i would, however, be very surprised (actually shocked) to learn that SSRIs are no better than a placebo. it should be noted that serotonin has been the key player in anti depressants since the dawn of anti depressants (tricyclic ADs).
Guest- Guest
Re: Serotonin Myth.
tricyclics ADs work not only on Serotonin but also other monoamine transporters.
There is plenty of evidence that SSRIs work for folks with depression but the drug companies falsely claiming that there is a scientific link between lack of serotonin leading to very complex mental issues, is the problem here.
The PLos article's point is that even after counterevidence FDA hasn't stopped these DTCAs and haven't regulated these drugs.
I will try and get the pdf of the article about st.John's wort and exercise and post it here.
Thanks for your comments.
There is plenty of evidence that SSRIs work for folks with depression but the drug companies falsely claiming that there is a scientific link between lack of serotonin leading to very complex mental issues, is the problem here.
The PLos article's point is that even after counterevidence FDA hasn't stopped these DTCAs and haven't regulated these drugs.
I will try and get the pdf of the article about st.John's wort and exercise and post it here.
Thanks for your comments.
doofus_maximus- Posts : 1903
Join date : 2011-04-29
Re: Serotonin Myth.
St. Johns Wort randomized clinical trial pdf article.
exercise and depression pdf
Like a true scientist I didn't read any of the above pdfs. I take the PLos journal article's word for them.
exercise and depression pdf
Like a true scientist I didn't read any of the above pdfs. I take the PLos journal article's word for them.
doofus_maximus- Posts : 1903
Join date : 2011-04-29
Re: Serotonin Myth.
ok doofus, let me ask you a blunt question. (these clinical studies are aplenty -- many are self selected -- and i will read your links tomorrow.)doofus_maximus wrote:St. Johns Wort randomized clinical trial pdf article.
exercise and depression pdf
Like a true scientist I didn't read any of the above pdfs. I take the PLos journal article's word for them.
my question is: do you honestly believe SSRIs do not alleviate depression (MDD)?
Guest- Guest
Re: Serotonin Myth.
I do believe they alleviate depression.
But I also agree with the authors' claim that depression is not a simple disease which can attributed to loss of an ubiquitous neurotransmitter.
I really like the analogy about aspirin or paracetomol. Just because taking aspirin or paracetomol alleviates headaches, it doesn't mean that headaches are caused because of lack of aspirin or paracetomol.
But I also agree with the authors' claim that depression is not a simple disease which can attributed to loss of an ubiquitous neurotransmitter.
I really like the analogy about aspirin or paracetomol. Just because taking aspirin or paracetomol alleviates headaches, it doesn't mean that headaches are caused because of lack of aspirin or paracetomol.
doofus_maximus- Posts : 1903
Join date : 2011-04-29
Re: Serotonin Myth.
+1doofus_maximus wrote:I do believe they alleviate depression.
But I also agree with the authors' claim that depression is not a simple disease which can attributed to loss of an ubiquitous neurotransmitter.
I really like the analogy about aspirin or paracetomol. Just because taking aspirin or paracetomol alleviates headaches, it doesn't mean that headaches are caused because of lack of aspirin or paracetomol.
Guest- Guest
Similar topics
» Interesting article: Understanding bodies-serotonin-connection-between-food-and-mood
» Ambedkar myth
» The myth about Sufis
» The myth of Julian Assange
» RAMANUJA MYTH AND REALITY
» Ambedkar myth
» The myth about Sufis
» The myth of Julian Assange
» RAMANUJA MYTH AND REALITY
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum